Medical
Pharmaceutical
Research And Development
Madrigal Pharmaceuticals
$92.479876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$92.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.51 (2.79%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell MDGL and other stocks, options, ETFs, and crypto commission-free!
About MDGL
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Read More The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.
Employees
17
Headquarters
West Conshohocken, Pennsylvania
Founded
2011
Market Cap
1.43B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
186.10K
High Today
$92.57
Low Today
$90.06
Open Price
$90.88
Volume
99.82K
52 Week High
$255.68
52 Week Low
$82.39
Collections
Medical
Pharmaceutical
Research And Development
Health
Cancer Prevention
Technology
Price Paid on Robinhood
35% Lower
Right Now
52 Week Low
$91.56
Average Price Paid
$143.10
52 Week High
$325.98
Analyst Ratings
64%
of 11 ratings
Buy
64%
Hold
27%
Sell
9%
MDGL Earnings
-$0.98
-$0.98
-$0.97
-$0.97
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
—